Proposes solutions with the project actors to the brand.
February 19, 2021
Works closely with the brands, the CDMOs, finance, supply chain, operations QRVi, and medical affairs to ensure that G1 and G2 decisions are respected.
January 24, 2021
Supports Regulatory in validation of Quantitative Ingredient list / INCIs.
December 14, 2020
Updates the activities and timings in the selected planning tool.
December 08, 2020
Reporting to the various participants is normalized according the product development team orientations (reporting to the brand and to the Head office).
November 29, 2020
Organizes impact analysis meeting with the team members involved to propose solutions to the brand.
October 17, 2020